https://www.healio.com/news/endocrinology/20210309/thyroid-disease-does-not-influence-covid19-progression https://www.healio.com/news/endocrinology/20210309/thyroid-disease-does-not-influence-covid19-progression Patients on thyroxine were more likely to have hospitalization/dialysis w/ COVID But at 60 days adverse outcome did not persist. Mild initial increase risk which does not persist
Answered 5/12/2021
0 views
A doctor has provided 1 answer
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question